A logo

AGILENT TECHNOLOGIES INC

ANYSE
πŸ† #306 by market capEarnings Nov 23 Β· PostUS Equity
$174.95β–Ό $0.26 (βˆ’0.15%)
Live
πŸ””
Track A
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.1%
7dβ–² 4.6%
14dβ–² 16.5%
30dβ–² 13.8%
ytdβ–² 28.5%
1yβ–² 41.4%
🏦Market Cap
$49.41B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+6.7%
Slowing
πŸ“ŠGross Margin
53.7%
Healthy
πŸ’΅FCF Margin
19.5%
Healthy
βš–οΈP/S Ratio
6.6x
Fair
Otter Score
80
Good

Trading Snapshot

Day Range
$172.65 – $176.57
52-Week Range
$108.35 – $174.77
Volume
$2.56B
Avg Volume
$2.63B
Shares Outstanding
282.4M
Next Earnings
Dec 3, 2026

Fundamentals Snapshot

Annual Revenue
$6.95B
Last Q Revenue
$1.88B
P/E Ratio
33.9
P/S Ratio
6.6x
EPS (TTM)
$5.11
Dividend Yield
0.59%
Dilution (1yr)
βˆ’2.4%

Why Investors Own A

  • βœ“High-growth profile β€” revenue up +54.9% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 43% gross margin and 6% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

A logo

AGILENT TECHNOLOGIES INC

A
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$6.9Bβ–² +6.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
52.4%β–Ό βˆ’3.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$1.5Bβ–Ό βˆ’0.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$1.2Bβ–Ό βˆ’16.1% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
284.0Mβ–Ό βˆ’2.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$1.6Bβ–² +$680M YoY
StockOtter Β· stockotter.space

About AGILENT TECHNOLOGIES INC

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Good
80/100

Analyst Ratings

β“˜
Consensus
Buy
30 analysts
Strong Buy8
Buy15
Hold7
Sell0
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates

Defense WorldΒ·3d ago

Agilent Technologies, Inc. (NYSE:A) Stock Now Rated β€œModerate Buy” by Sell-Side Brokerages

Shares of Agilent Technologies, Inc. (NYSE: A - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the twenty research firms that are covering the stock, MarketBeat reports. Five analyst

Zacks Investment ResearchΒ·4d ago

Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?

Agilent (A) reported earnings 30 days ago. What's next for the stock?

Seeking AlphaΒ·6d ago

Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript

Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript

MarketBeatΒ·6d ago

Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation

Agilent Technologies NYSE: A executives outlined continued growth momentum, driven by improving end markets, market-share gains, instrument replacement cycles and operational changes under the company's Ignite transforma

Business WireΒ·8d ago

Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStationDx software, extendi

Defense WorldΒ·12d ago

Bank of America Corp DE Makes New Investment in Agilent Technologies, Inc. $A

Bank of America Corp DE purchased a new stake in Agilent Technologies, Inc. (NYSE: A) in the undefined quarter, according to its most recent filing with the SEC. The fund purchased 1,605,576 shares of the medical researc